Ageing-related diseases and cancer pose new challenges for medicine and healthcare. Innovative molecular biological methods shall tackle these and enable early diagnostics. At the Biomarker Symposium in Vienna, well known experts from 11 countries will be discussing the latest trends in biomarker development and early diagnostics.
The 2nd “Austrian Biomarker Symposium on Early Diagnostics” takes place in Vienna, at Tech Gate between March 31 – April 1, 2014 and offers a unique overview on the biomarker technologies used for early diagnostics. Among the more than 30 speakers of the two-day-event, you will find several prominent experts from the academic, clinical and economic fields, like David Wong, Pioneer of Saliva Biomarker Research from UCLA.
Molecular search for traces
Biomarkers are the body’s own molecules characteristic for certain diseases and detectable with the latest technologies. They facilitate not only early diagnostics but also targeted therapy and contribute a lot to prevention, in connection with diabetes and cancer, for example. The research in this field is intensiveon an international level, but at AIT as well. The goal is to develop technologies that enable early diagnostics and respective quick tests. Researchers search for traces not only in blood but also in saliva since this form of early diagnostics opens new doors for precaution and therapy monitoring.
Not only biomarkers will be in focus at the Symposium but also topics contributing to better diagnostics and earlier diagnoses, for example bioinformatics and sensor technologies for point-of-care devices. Marketability and end use of these devices will, of course, also be discussed – from screening to prototype.
For further information, go to: www.biomarker-development.com
2nd Austrian Biomarker Symposium 2014 on Early Diagnostics
Tech Gate Vienna